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ouble-strand breaks (DSBs) are highly toxic lesions that
need to be repaired accurately in order to avoid chro-
mosomal instability, a hallmark of various human dis-
orders, including cancer. Mammalian cells respond to DSBs by
activating a complex network of signaling pathways generally
referred to as the DNA damage response (DDR)1, which regulates
various cellular processes such as the induction of cell-cycle
checkpoints, apoptosis or senescence and the coordination of
DNA repair pathway choice.
Central players in the cellular response to DSBs are the
phosphoinositide 3-kinase (PI3K)-related protein kinases
(PIKKs), including ataxia-telangiectasia mutated (ATM) and
ATM and RAD3-related (ATR). ATM functions mainly in
response to DSBs while ATR is activated by a much wider range
of genotoxic insults. Both ATM and ATR require specific cofac-
tors for their recruitment and optimal activation. The MRE11/
RAD50/NBS1 (MRN) complex is required for ATM and ATR
activation in response to DSBs2–5. ATR is recruited to sites of
DNA damage via its interacting protein ATRIP that binds to
ssDNA coated with the ssDNA-binding protein RPA (RPA-
ssDNA)6. Such RPA-ssDNA is generated by nucleolytic proces-
sing of DNA lesions or by the uncoupling of DNA polymerases
and helicases during DNA replication7. Several additional
cofactors are required for the optimal activation of ATR at sites of
DNA damage. Among these, the best studied is TOPBP1, which
contains an ATR activation domain (AAD) that stimulates ATR
kinase activity8.
DSBs also induce transcriptional repression9–14. This effect has
first been described in the nucleoli where the ribosomal gene
(rDNA) arrays that make up for the highest transcribed sites in
the human genome are located9. In human cells, ~300 rDNA
repeats are distributed among nucleolar organizer regions
(NORs). The NORs are located on the short arms of the five
acrocentric chromosomes and encode the precursor ribosomal
RNA (pre-rRNA) that is synthesized by the RNA polymerase I
(Pol I) transcription machinery. Nucleoli are composed of three
distinct subdomains that reflect the stages of ribosome biogenesis.
Fibrillar centers (FCs) contain pools of transcription factors and
non-transcribed rDNA sequences. Pol I transcription takes place
at the interface between FCs and the surrounding dense fibrillar
component (DFC) where early processing of the synthesized pre-
rRNA occurs. FCs and DFC are embedded in the granular
component (GC) where late processing of pre-rRNAs occurs,
yielding mature rRNAs that together with the ribosomal proteins
assemble into ribosome subunits15.
The induction of breaks in the rDNA repeats triggers rapid
ATM-dependent shutdown of Pol I transcription in the nucleoli9.
Transcriptional repression is accompanied by a large-scale
structural alteration of the nucleoli whereby the rDNA repeats
along with associated proteins translocate from inside the nucleoli
into the nucleolar periphery, where they accumulate in focal
structures that are called nucleolar caps16–19. These structural
changes—often referred to as nucleolar segregation—are also
induced by inhibition of Pol I transcription by small-molecule
inhibitors, thus suggesting that transcriptional repression is the
underlying cause of nucleolar segregation20. While nucleolar
segregation has been proposed to facilitate the repair of rDNA
breaks16,17,19, the mechanism by which ATM signaling sup-
presses rRNA transcription and the functional implication of
transcriptional repression and nucleolar segregation have not yet
been studied in detail.
We and others recently discovered that NBS1, a subunit of the
MRN complex, is rapidly and transiently recruited in the
nucleoli in response DSBs21,22. This recruitment event is depen-
dent on a direct phosphorylation-dependent interaction between
the N-terminal FHA/BRCT region of NBS1 and Treacle (also
called TCOF1), a low complexity nucleolar phosphoprotein
whose gene is mutated in Treacher-Collins syndrome, a con-
genital disorder of craniofacial development23. Even though
nucleolar localization of NBS1 has been associated with tran-
scriptional repression of the rDNA repeats, the exact mechanism
by which NBS1 contributes to the shutdown of Pol I transcription
remains elusive.
Here we show that transcriptional repression and nucleolar
segregation in response to targeted induction of DSBs in the
rDNA repeats depend on both ATM and ATR activity. We fur-
thermore show that Treacle recruits the ATR activator TOPBP1
in the nucleoli in an ATM- and NBS1-dependent manner.
Mechanistically, TOPBP1 is recruited through direct
phosphorylation-dependent interactions with the C-terminal
region of Treacle. We propose that Treacle orchestrates the
nucleolar response to rDNA breaks primarily through recruiting
the two key adaptors NBS1 and TOPBP1 in the nucleoli, both of
which are implicated in ATR activation.
Results
ATR-dependent Pol I inhibition and nucleolar segregation. In
order to follow the dynamics of the cellular response to rDNA
breaks in real time, we generated U2OS cell lines stably expres-
sing low levels of green fluorescence protein (GFP)-tagged Treacle
(Supplementary Fig. 1a). Characterization of these cell lines
showed that GFP-Treacle exhibited the same subcellular locali-
zation as the endogenous Treacle, concentrating at the FC and
DFC within the nucleoli (Fig. 1a). To induce targeted breaks in
the rDNA repeats, we adopted the I-Ppo1 mRNA transfection
approach previously described16. I-Ppo1 recognizes a sequence
within the 28S portion of the rDNA repeat as well as a few sites
elsewhere in the genome24. Live-cell microscopy was used to
monitor changes in GFP-Treacle localization and changes in
nucleolar morphology over time. Upon induction of breaks in the
rDNA repeats, GFP-Treacle foci rapidly fused to form a few
bright centers within the nucleoli before they migrated in the
nucleolar periphery. At the same time, the nucleoli changed from
irregularly shaped to round. By 120 min post I-Ppo1 mRNA
transfection, the majority of nucleoli in the transfected cell
population had completely segregated (Fig. 1a and Supplemen-
tary Movie 1).
We next asked if the DDR is implicated in the translocation
of GFP-Treacle from inside the nucleoli to the nucleolar
periphery in response to rDNA breakage. Surprisingly, we
found that nucleolar segregation is not only blocked by ATM
inhibitors, but also by ATR inhibitors (Supplementary Fig. 1b).
We next assessed the localization of endogenous Treacle in
response to I-Ppo1 mRNA transfection by quantitative 3D
confocal microscopy (Supplementary Fig. 2a). These studies
confirmed that migration of endogenous Treacle to the
nucleolar periphery as well as changes in the nucleolar volume
and sphericity in response to rDNA breaks are dependent on
both ATM and ATR activity (Fig. 1c, d, Supplementary Fig. 2c).
We observed that nucleolar segregation is blocked by ATR
inhibitors in the majority of cells, irrespective of the cell-cycle
stage (Supplementary Fig. 2d). The differences between control
cells and inhibitor treated cells were not caused by variability in
the I-Ppo1 expression levels nor did inhibitor treatment affect
I-Ppo1 translation (Supplementary Fig. 3a–c). We next
investigated ATM- and ATR recruitment to sites of I-Ppo1-
induced DSBs in the nucleoli. Both ATM and ATR first
accumulated inside of the nucleoli and at later timepoints,
localized to nucleolar caps (Fig. 1e, Supplementary Fig. 2b). We
also assessed ATM and ATR downstream signaling in response
to I-Ppo1 transfection. CHK2 was efficiently phosphorylated on
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Thr68 in an ATM-dependent manner, and CHK1 was
phosphorylated on both Ser317 and Ser345 in an ATR-
dependent manner (Supplementary Fig. 1c).
Next, we measured transcriptional activity within the nucleoli
in response to rDNA breaks by 5-ethynyl uridine (EU) RNA
labeling followed by Click-iT chemistry and by quantitative real-
time PCR (qRT-PCR). Both assays showed strong ATM and ATR
dependency of Pol I transcriptional inhibition in response to
targeted induction of rDNA breaks by I-Ppo1 and in response to
ionizing radiation (Fig. 1f, g and Supplementary Fig. 1d, e).
Notably, CHK1 and CHK2 inhibition by two small-molecule
inhibitors also significantly compromised transcriptional inhibi-
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In summary, these data reveal that transcriptional inhibition
and nucleolar segregation in response to rDNA breakage require
both ATM and ATR activity throughout the cell cycle.
NBS1 regulates the nucleolar response to rDNA breaks. As we
and others previously showed that NBS1 interacts with Treacle
and is rapidly recruited in the nucleoli in response to DSBs in an
ATM- and Treacle-dependent manner21,22, we next wished to
determine if NBS1 is also implicated in the nucleolar response to
I-Ppo1 expression. To this end, we targeted exon 2 of NBS1 in
U2OS cells using CRISPR-Cas9 and isolated several clones with
no detectable expression of full-length NBS1 (Supplementary
Fig. 4a–c). One clone was subsequently analyzed in detail. Similar
to cell lines derived from Nijmegen breakage syndrome patients,
NBS1 knock-out U2OS cells showed increased radio-sensitivity,
displayed defects in G2/M checkpoint activation, DSB resection
and ATR activation in response to ionizing radiation (IR), and
had MRE11 predominantly localized in the cytoplasm (Supple-
mentary Fig. 5a–f). As it was recently shown that the C-terminal
MRE11-interacting region in NBS1 is sufficient for viability and
ATM activation25, we suspected that the NBS1 knock-out U2OS
cells may express a hypomorphic C-terminal fragment of NBS1.
Indeed, the NBS1 mRNA is overexpressed in these cells and they
express low levels of an ~40 kDa protein that is responsive to
NBS1 mRNA knockdown by siRNA (Supplementary Fig. 5g, h).
Based on these findings, we concluded that these cells most likely
express low levels of a truncated NBS1 protein lacking the N-
terminus. Therefore, we henceforth refer to these cells as
NBS1ΔN.
We next addressed the role of NBS1 in transcriptional
repression and nucleolar segregation in response to I-Ppo1
transfection. No nucleolar segregation was evident in NBS1ΔN
cells within the first 2 h after transfection with I-Ppo1. (Fig. 2a).
In addition, Pol I inhibition upon I-Ppo1 expression was
compromised in NBS1ΔN cells (Fig. 2b). We next constructed
NBS1ΔN cell lines stably expressing full-length NBS1, tagged at
the C-terminus with the bright monomeric GFP variant mNeon-
Green (mNG). Time-lapse microscopy of these cells revealed
normal nucleolar segregation in response to I-Ppo1 expression. In
addition, we consistently observed that NBS1-mNG is recruited
into the nucleoli prior to nucleolar segregation (Fig. 2c, d,
Supplementary Movie 2). NBS1-mNG co-localized with Treacle
in the nucleoli and the introduction of point mutations in the N-
terminal FHA and BRCT domains of NBS1 that have previously
been shown to abrogate their ability to interact with phosphory-
lated proteins (R28A, K160M)26, compromised nucleolar recruit-
ment of NBS1 (Fig. 2e). Since NBS1 contacts Treacle via its FHA/
BRCT domains21, these data suggest that direct interaction with
Treacle may also mediate its recruitment in the nucleoli. Indeed,
depletion of endogenous Treacle by siRNA strongly reduced
NBS1 nucleolar recruitment in response to I-Ppo1 expression
(Fig. 2f). Treacle-mediated recruitment of NBS1 was prevented by
ATM and ATR inhibition (Supplementary Fig. 6a). Since we also
observed MRE11 recruitment in the nucleoli after I-Ppo1
transfection (Supplementary Fig. 6b), we propose that NBS1 acts
in the nucleolar response to rDNA breaks in the context of the
entire MRN complex.
In summary, these results confirm that the MRN complex is an
essential upstream component of the signaling pathways that
regulate transcriptional repression and nucleolar segregation in
response to rDNA breaks9,21.
rDNA resection occurs downstream of ATR activation. The
MRN complex has been proposed to act upstream of ATR acti-
vation in response to DSBs through its essential role in DNA end
resection, which produces ssDNA, the main signal recognized by
ATR4,5,27. We therefore considered the possibility that ATM- and
MRN-dependent resection of rDNA breaks may be required for
ATR activation in the nucleoli. I-Ppo1 expression triggered the
accumulation of the ssDNA binding protein RPA within
nucleolar caps (Fig. 3a). In addition, RPA2, phosphorylated on
Ser4 and Ser8 (RPA2 pS4/8), an established marker for resection,
was also enriched within nucleolar caps (Supplementary Fig. 7a).
At early time points after I-Ppo1 transfection, we observed RPA
foci also inside the nucleoli, suggesting that DNA end resection
occurs already before the broken rDNA repeats have moved out
of the nucleoli (Fig. 3a). It was proposed that breaks in the rDNA
repeats are resected throughout the cell cycle16. However, we
found strong cell cycle dependency of RPA foci formation within
the first 2 h after I-Ppo1 transfection, with only Cyclin A-positive
S/G2-phase cells showing significant accumulation of RPA in the
nucleolar periphery (Fig. 3b, c and Supplementary Fig. 7b, c).
In NBS1ΔN cells, no RPA foci formed within the first 2 h after
I-Ppo1 transfection (Fig. 3d, e). RPA pS4/8 foci were also strongly
reduced in NBS1ΔN cells and by the MRE11 inhibitor Mirin,
indicating that resection of broken rDNA is dependent on the
nuclease activity of MRN complex (Supplementary Fig. 7a).
Surprisingly, we observed that treatment of cells with ATM and
ATR inhibitors prior to I-Ppo1 transfection strongly abrogated
RPA foci formation, suggesting that DNA end resection is not
required for ATR activation in the nucleoli (Fig. 3f, g). In support
of this, depletion of the DNA end resection factor CtIP failed to
compromise nucleolar segregation, even though it strongly
inhibited RPA foci formation in response to I-Ppo1 expression
(Supplementary Fig. 7d).
These findings thus reveal a difference in the regulation of
DNA end resection between DSBs induced in the rDNA repeats
as compared to DSBs induced elsewhere in the genome that do
not require ATR activity for resection.
Fig. 1 ATR-dependent Pol I inhibition and nucleolar segregation. a Time-lapse microscopy of U2OS cells expressing low levels of GFP-tagged Treacle, after
transfection with I-Ppo1. b Timeline of the morphological changes of the nucleoli after I-Ppo1 transfection. c Morphological changes of the nucleoli after
I-Ppo1 transfection in ATMi (KU-55933) and ATRi (VE-821) treated cells. Displayed are maximum intensity projections of confocal z-stacks. NPM stands for
nucleophosmin d Quantification of Treacle foci number per nuceolus, nucleolar volume and nucleolar sphericity by segmentation of 3D reconstituted
z-stacks. DMSO/0min n= 262, DMSO/60min n= 239, DMSO/120min n= 264, ATMi/0min n= 174, ATMi/60min n= 166, ATMi/120min n= 179,
ATRi/0min n= 208, ATRi/60min n= 218, ATRi/120min n= 201 independent cells. Bars represent means, dotted lines within the violin plots represent
median and quartiles. e ATM and ATR recruitment to sites of nucleolar DSBs in response to I-Ppo1 transfection. Displayed are maximum intensity
projections of confocal z-stacks. NPM stands for nucleophosmin. f Quantification of nucleolar EU incorporation after I-Ppo1 transfection in I-Ppo1 H98A/
DMSO (n= 215), DMSO (n= 205), ATMi (KU-55933, n= 206) and ATRi (VE-821, n= 219) treated cells. g Quantification of nucleolar EU incorporation in
siCtrl I-Ppo1 H98A and WT (n= 203) and siATR I-Ppo1 H98A and WT (n= 210) treated cells. h Quantification of nucleolar EU incorporation after I-Ppo1
H98A (n= 229) and I-Ppo1 WT transfection in control (DMSO, n= 231), ATRi (VE-821, n= 237), CHK1i/CHK2i (AZD7762, n= 246) and CHK1i (GDC-
0575, n= 255) treated cells. f–h Boxes represent the 25–75 percentile range with median and whiskers represent the 5–95 percentile range. Data points
outside of this range are shown individually. All scalebars= 10 µm. Source data are provided as a Source Data file.
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TOPBP1 recruitment in response to rDNA breaks. Having
established that DNA end resection is not required for nucleolar
segregation in response to I-Ppo1 expression and occurs down-
stream of ATR activation, we next wished to investigate the
mechanism of ATR activation in the nucleoli. The ATR activator
TOPBP1 was previously implicated in nucleolar stress responses
and its overexpression was shown to trigger ATR-dependent Pol I
inhibition and nucleolar segregation even in the absence of rDNA
damage28. Upon induction of rDNA breaks by I-Ppo1, TOPBP1
first accumulated inside of the nucleoli where it co-localized with
Treacle. At later timepoints, after nucleolar segregation had taken
place, TOPBP1 accumulated in nucleolar caps (Fig. 4a).
We next asked if TOPBP1 recruitment in the nucleoli is
dependent on NBS1, ATM and ATR activity. Only few
NBS1ΔN cells contained nucleolar TOPBP1 foci, and expres-
sion of wild-type NBS1 but not FHA/BRCT mutated NBS1
rescued this defect (Fig. 4b). In addition, TOPBP1 accumula-
tion in nucleolar caps was also blocked by pre-treatment of cells
with either ATM or ATR inhibitors (Fig. 4c, d). Interestingly
though, TOPBP1 foci did form within the nucleoli of a
substantial percentage of ATR-inhibited U2OS cells, suggesting
that not the initial recruitment of TOPBP1 but rather its
subsequent accumulation in the nucleolar periphery is depen-
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Fig. 2 NBS1 regulates the nucleolar response to rDNA breaks. a Timecourse of endogenous Treacle localization after I-Ppo1 transfection in normal U2OS
cells and NBS1ΔN cells. b Quantification of nucleolar EU incorporation after I-Ppo1 H98A (n= 111) and I-Ppo1 WT (n= 87) transfection in control U2OS
and after I-Ppo1 H98A (n= 116) and I-Ppo1 WT (n= 124) transfection in NBS1ΔN cells (boxes represent the 25–75 percentile range with median and
whiskers represent the 5–95 percentile range. Data points outside of this range are shown individually). c Time-lapse microscopy of U2OS cells expressing
mNG-tagged full-length NBS1 (wild type), after transfection with I-Ppo1. d Timeline of NBS1-mNG recruitment in relation to morphological changes in the
nucleoli after I-Ppo1 transfection. e Confocal microscopy of NBS1-mNG wild type and point mutants in the NBS1ΔN background. f Localization of
endogenous NBS1 2 h after I-Ppo1 transfection in siCtrl and siTreacle-treated cells (percentages of cells with >2 NBS1 caps are indicated; one of two
experiments is shown). All scalebars= 10 µm. Source data are provided as a Source Data file.
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Fig. 3 rDNA resection occurs downstream of ATR activation. a Timecourse of RPA2 foci formation in U2OS cells after I-Ppo1 transfection. b Timecourse
of RPA2 foci formation in cells counterstained for Cyclin A. c Quantification of the experiment in b (all data points shown, red bars represent mean).
d Timecourse of RPA2 foci formation in U2OS WT and NBS1ΔN cells after I-Ppo1 transfection. e Quantification of the experiment in d (all data points
shown, red bars represent mean). f Timecourse of RPA2 foci formation in U2OS cells treated with ATMi (KU-55933) and ATRi (VE-821) after I-Ppo1
transfection. g Quantification of the experiment in f (all data points shown, red bars represent mean). All scalebars= 10 µm. Source data are provided as a
Source Data file.
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Fig. 4 TOPBP1 recruitment in response to rDNA breaks. a Timecourse of TOPBP1 localization in GFP-Treacle expressing U2OS cells after I-Ppo1
transfection. b TOPBP1 localization 2 h after I-Ppo1 transfection in NBS1ΔN cells and NBS1ΔN cells complemented with wild-type and mutant NBS1-mNG
(percentage of cells with > 2 TOPBP1 caps are indicated; one of two experiments is shown). c TOPBP1 localization 2 h after I-Ppo1 transfection in ATMi- and
ATRi-treated cells versus vehicle (DMSO)-treated cells (percentage of cells with TOPBP1 foci inside of the nucleoli are indicated; one of two experiments is
shown). d Quantification of cells with TOPBP1 caps after ATMi and ATRi treatment versus vehicle (DMSO) treatment (red bars represent mean).
e Quantification of nucleolar EU incorporation after I-Ppo1 H98A (n= 692) and I-Ppo1 WT (n= 649) transfection in control U2OS and after I-Ppo1 H98A
(n= 450) and I-Ppo1 WT (n= 521) transfection in siTOPBP1-treated cells (boxes represent the median with 25–75 percentile range and whiskers
represent the 5–95 percentile range. Data points outside of this range are shown individually). f Endogenous Treacle localization 2 h after I-Ppo1
transfection in control siRNA and TOPBP1 siRNA transfected cells (percentage of cells with > 2 Treacle caps are indicated; one of two experiments is
shown). g TOPBP1 localization in Treacle-depleted U2OS cells and control cells 2 h after I-Ppo1 transfection (percentage of cells with > 2 TOPBP1 caps are
indicated; one of two experiments is shown). h HA-immunoprecipitations from 293FT cells transfected with the indicated HA-tagged Treacle variants, in
the presence or absence of ATMi and ATRi and with and without IR treatment as indicated. STTT mutated Treacle: S171A, T173A, T203A, T210A. All
scalebars= 10 µm. Source data are provided as a Source Data file.
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Downregulation of TOPBP1 expression in U2OS cells by siRNA
significantly compromised transcriptional inhibition in response to
I-Ppo1 expression (Fig. 4e and Supplementary Fig. 8a). Moreover,
downregulation of TOPBP1 also blocked nucleolar segregation in
the majority of cells (Fig. 4f). Based on the observation that TOPBP1
interacts with components of the MRN complex29,30, we considered
the possibility that the MRN complex may recruit TOPBP1 in the
nucleoli through direct interaction. Consistent with this idea,
downregulation of Treacle, the nucleolar adaptor for NBS1, also
severely compromised TOPBP1 nucleolar recruitment and cap
formation in response to rDNA damage (Fig. 4g). However, co-
immunoprecipitation experiments revealed that HA-tagged Treacle
mutants that lack the NBS1 interaction sites21 still efficiently co-
immunoprecipitated TOPBP1. Moreover, TOPBP1–Treacle com-
plex formation was constitutive and did not depend on DNA
damage or ATM and ATR activity (Fig. 4h). These data suggested
that TOPBP1 may interact with Treacle directly and not via the
MRN complex. In support of this idea, and consistent with previous
findings31, we identified Treacle as a candidate TOPBP1-interacting
protein by mass spectrometric analysis of TOPBP1-associated
proteins both in the presence and absence of DNA damage
(Supplementary Fig. 9a, b and Supplementary Data 1).
In summary, these data reveal that TOPBP1 is an important
regulator of the nucleolar response to rDNA damage and suggest
that the MRN complex and Treacle mediate the recruitment of
TOPBP1 in the nucleoli in response to rDNA breaks for
subsequent ATR activation.
Characterization of the TOPBP1–Treacle interaction. We next
sought to characterize the TOPBP1–Treacle interaction in more
detail. Treacle consists of three structurally distinct regions: an
N-terminal region that contains the phosphorylated Ser and Thr
residues required for NBS1 interaction21, a central region con-
sisting of 10 consecutive acidic and serine-rich sequence stretches
and a C-terminal region containing nuclear and nucleolar loca-
lization signals (Fig. 5a). In order to map the region of Treacle
required for its interaction with TOPBP1, we generated a series of
deletion mutants of HA-tagged Treacle and assessed their impact
on the interaction with TOPBP1 by co-immunoprecipitation
experiments. These data revealed that the main TOPBP1 inter-
action site is located within the C-terminal part of Treacle and
that the NBS1 and TOPBP1 interaction sites on Treacle are dis-
tinct and do not overlap (Fig. 5b).
TOPBP1 is a modular protein consisting of nine BRCT
domains (numbered from 0 to 8), two of which occur in tandems,
one in a unique triple-BRCT configuration, and two appear to
function as single domains32,33. BRCT 1, 2, 5 and 7 contain the
necessary residues for phosphopeptide binding34. The AAD is
located between BRCT domains 6 and 7 (Fig. 5c). BRCT tandems
usually contain a conserved lysine residue that directly contacts
the phosphate group of a modified protein ligand35. Mutating
such residues significantly reduces ligand-binding affinity. We
therefore mutated Lys residues in BRCT domains 1, 2, 5 and 7 to
Ala in GFP-tagged full-length TOPBP1 and used these constructs
in co-immunoprecipitation experiments. The analysis showed
that, in accordance with previous work, mutation of TOPBP1
BRCT1 abolished TOPBP1 interaction with RAD9 but not with
BLM, whereas mutation of BRCT5 disrupted TOPBP1 interaction
with BLM but had little effect on RAD9 binding to TOPBP1
(Fig. 5d)36,37. Surprisingly, mutation of three BRCT domains (1, 2
and 5) completely abolished Treacle binding to TOPBP1, thus
suggesting the presence of three phosphorylated TOPBP1 binding
sites in Treacle (Fig. 5d). Of the three purified BRCT tandems
fused to GST, only BRCT0-2 pulled down significant amounts of
Treacle from Hela nuclear extracts (Supplementary Fig. 8c)
suggesting that interaction of Treacle with the isolated TOPBP1
BRCT4+ 5 may be too weak for detection in a GST-pulldown
experiment.
A conserved TOPBP1 phospho-interaction motif in Treacle.
Since complex formation with Treacle requires the phosphopeptide-
































































































Fig. 5 Characterization of the TOPBP1–Treacle interaction. a Schematic
showing the layout of conserved domains and motifs in Treacle as well as
HA-tagged deletion constructs of Treacle, lacking either the N-terminal
region (F1), both the N-terminal and the central repeat region (F2), the
central repeat region (F3), the C-terminal region (F4) or both the central
repeat and the C-terminal region (F5). HA-immunoprecipitation of full-
length and five deletion constructs depicted in a. c Schematic showing the
layout of conserved domains and motifs in TOPBP1. Names of known
TOPBP1-binding partners are shown below the domains they interact with
and phospho-interacting Lys residues in the three BRCT tandems are
highlighted. AAD: ATR-activating domain. d GFP-pulldowns from
293FT cells transfected with the indicated GFP-tagged TOPBP1 constructs.
Source data are provided as a Source Data file.
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mapped phosphorylation sites within the C-terminal region of
Treacle by mass spectrometry. Several Ser/Thr phospho-residues
were identified with high (>90%) positional probability (Supple-
mentary Data 2). Of these, only a few are conserved. Three phos-
phorylation sites (Thr1223, Ser1227 and Ser1228) within a highly
conserved acidic sequence stretch stand out because along with
their surrounding amino acids, they bear significant similarities
to known TOPBP1 BRCT0-2 interaction motifs in RAD9 and
Treslin (Supplementary Fig. 8d)31,36. Interestingly, a highly con-
served Ser/Gln (SQ) motif (the ATM/ATR target motif) previously
suggested to interact with NBS122 is located immediately down-
stream of the putative BRCT0-2 interaction site. In addition, amino
acids N-terminal of this SQ motif closely resemble the TOPBP1
BRCT4-5 interaction site in BLM (Supplementary Fig. 9d)37,38.
Mutating the central two Ser residues within the putative TOPBP1
BRCT0-2 recognition site severely compromised TOPBP1–Treacle
interaction (Fig. 6a). Mutation of the conserved SQ motif also
slightly reduced the binding of HA-tagged Treacle to endogenous
TOPBP1.
We next sought to investigate if mutation of these phospho-
residues in Treacle would affect TOPBP1 recruitment in the
nucleoli and transcriptional repression in response to rDNA
breaks. To this end, we generated cell lines stably expressing
siRNA-resistant GFP-tagged full-length Treacle (wild type and
point mutants, respectively) and assessed in each cell line how
well ectopic expression of Treacle could rescue the effect of
endogenous Treacle downregulation. The analysis showed that
in mock-transfected cells, downregulation of endogenous
Treacle almost completely abrogated TOPBP1 nucleolar
accumulation (Fig. 6b, c). This defect was rescued to control
levels by stable ectopic expression of GFP-tagged wild-type
Treacle. However, none of the mutants was able to fully
complement for the loss of endogenous Treacle expression.
Notably, the triple mutant was almost completely defective for
TOPBP1 accumulation. In addition, the mutant Treacle-
expressing cells showed significantly higher levels of nucleolar
EU incorporation after I-Ppo1 transfection when endogenous
Treacle was depleted, suggesting a defect in I-Ppo1-induced
transcriptional repression in the absence of Treacle–TOPBP1
interaction (Fig. 6d).
In summary, these data reveal that phosphorylation-dependent
TOPBP1 binding to a conserved sequence motif within the
Treacle C-terminal domain is essential for its recruitment in the
nucleoli and is necessary for optimal transcriptional repression in
response to rDNA breaks.
Treacle- and TOPBP1-mediated nucleolar recruitment of ATR.
The mechanism of ATR activation by TOPBP1 is not well
understood. We thus considered the possibility that TOPBP1 may
mediate ATR recruitment in the nucleoli in response to rDNA
breaks. ATR localization in the nucleoli was strongly reduced in
Treacle- and TOPBP1-depleted cells (Fig. 7a, b), suggesting that
Treacle- and TOPBP1-mediated accumulation of ATR in the
nucleoli may be required to ensure transcriptional repression and
nucleolar segregation in response to rDNA breaks. In support of
this idea, we observed that TOPBP1 overexpression not only
triggered nucleolar segregation as previously reported28, but it
also mediated robust ATR accumulation in nucleolar caps
(Fig. 7d). ATR activation by TOPBP1 relies on a conserved
tryptophan residue that lies within the AAD (W1145). Both
nucleolar segregation and ATR accumulation were completely
abrogated upon overexpression of a W1145R mutant version of
TOPBP1 even though this mutant was still enriched in the
nucleoli where it co-localized with Treacle (Fig. 7d, Supplemen-
tary Fig. 8d). In Treacle-depleted cells, overexpression of
wild-type TOPBP1 did not trigger nucleolar segregation (Fig. 7e).
In summary, these findings support the idea that the nucleolar
response to rDNA breaks depends on Treacle- and TOPBP1-
mediated accumulation of ATR in the nucleoli.
Loss of Treacle and TOPBP1 impairs rDNA repair. We next
aimed to establish the physiological significance of TOPBP1/ATR-
mediated transcriptional inhibition and nucleolar segregation.
Previous studies suggested that these events are required for effi-
cient repair of rDNA breaks17–19. We therefore studied recruitment
of the DSB repair machinery in response to rDNA breaks in
Treacle- and TOPBP1-deficient cells. Depletion of either Treacle or
TOPBP1 by siRNA prior to rDNA damage resulted in significantly
reduced H2AX phosphorylation and 53BP1 accumulation in the
nucleolar periphery. Moreover, Treacle- and TOPBP1-depleted cells
were also unable to efficiently recruit RPA and the homologous
recombination (HR) factors BRCA1 and RAD51 to nucleolar caps
after I-Ppo1 treatment (Fig. 8a–d).
We next depleted Treacle and TOPBP1 by siRNA and
measured cell viability in cells transfected with I-Ppo1 mRNA.
Depletion of both Treacle and TOPBP1 resulted in a reduced
ability of cells to survive DNA damage induced by I-Ppo1
transfection (Fig. 8e). In addition, NBS1ΔN cells were also
hypersensitive to I-Ppo1 mRNA transfection when compared to
wild-type U2OS cells (Fig. 8f). While the reduced survival may be
caused by defective rDNA repair, we cannot rule out a
contribution of defective DSB repair at I-Ppo1 sites that are
located outside of the rDNA repeats.
Taken together, these data highlight the importance of Treacle
as a nucleolar-specific adaptor for NBS1 and TOPBP1 and
support a model in which these DDR factors accumulate in the
nucleoli upon rDNA breakage in order to recruit and activate the
ATR kinase, whose activity is required to repress Pol I
transcription and mediate migration of the broken rDNA repeats
out of the nucleoli into nucleolar caps, where they can be
efficiently accessed by the DSB repair machinery (Fig. 8g).
Discussion
The findings reported here reveal a role of ATR kinase activity in
the suppression of Pol I transcription and nucleolar segregation
in response to rDNA breaks. ATR’s role in DSB-induced cell-
cycle checkpoint activation is well established39. However, its role
in the cellular response to DSBs was mostly assigned to S/G2
phases of the cell cycle when sister chromatids are present. This is
because extensive regions of RPA-coated ssDNA (RPA-ssDNA), a
well-established signal for ATR activation, are not generated at
sites of DSBs in G1-phase cells as DNA end resection that gen-
erates 3′ ssDNA overhangs is suppressed in G1 (ref. 40). Despite
this well-established model, evidence for ATR activation in G1-
phase cells has been recently presented41,42. We report here that
repression of Pol I transcription and nucleolar segregation are
dependent on ATR activity throughout the cell cycle, even in G1
phase, when no sister chromatids are present, and resection of
broken rDNA does not take place. Our data thus challenge the
current view that RPA-ssDNA is an essential signal for ATR
activation in response to DSBs and suggest that ATR may be
efficiently activated without RPA-ssDNA in the nucleoli.
Accordingly, there is evidence that extensive regions of RPA-
ssDNA may not be the signal for ATR activation in response to
DSBs also outside of the nucleoli43–45.
An important element in the process of transcriptional
repression and nucleolar segregation in response to rDNA breaks
is the accumulation of the MRN complex and TOPBP1 in the
nucleoli. Depletion of Treacle not only abrogates recruitment of
both MRN and TOPBP1 in the nucleoli, but also results in
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13981-x ARTICLE
NATURE COMMUNICATIONS |          (2020) 11:123 | https://doi.org/10.1038/s41467-019-13981-x | www.nature.com/naturecommunications 9
defective recruitment of ATR in the nucleoli and renders cells
incapable to undergo nucleolar segregation. However, Treacle-
mediated recruitment of the MRN complex and TOPBP1 are
unlikely to represent the initial signal for ATM and ATR acti-
vation in the nucleoli. We therefore consider it more likely that
Treacle lies in the center of an auto-amplification mechanism,
which ultimately leads to the accumulation of ATR in the
nucleoli. Several lines of evidence support this notion: first,
efficient Treacle-mediated accumulation of NBS1 and TOPBP1
requires ATM and ATR activity, indicating that the initial acti-
vation of these kinases at sites of rDNA breaks occurs indepen-
dently of Treacle. Second, TOPBP1 recruitment in the nucleoli
occurs independently of ATR in a subset of cells, and third,
overexpression of TOPBP1 leads to ATR-dependent transcrip-
tional repression in the nucleoli followed by nucleolar segregation
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Our data show that the interaction between Treacle and
TOPBP1 is constitutive and DNA damage independent. The
TOPBP1 interaction site in Treacle closely resembles known
interaction motifs of the TOPBP1 BRCT0-2 module in RAD9 and
Treslin31,36,46. In addition, our data are consistent with a con-
stitutive and direct interaction between Treacle and TOPBP1
BRCT0-2. While BRCT4+ 5 appear to be also required for stable
association between TOPBP1 and Treacle in cells, they do not
efficiently interact with Treacle on their own. The reason for this
is currently not clear but the sequence similarity of the motif
around Ser1236 in Treacle with the TOPBP1 interaction site in
BLM makes it a promising candidate for a TOPBP1 BRCT4+ 5
interaction site37. Further biochemical work is needed to identify
the TOPBP1 BRCT4+ 5 interaction site in Treacle.
Our analysis revealed that DNA end resection of broken rDNA
repeats takes place in S/G2 cells. This observation differs from the
data presented by a previous work16 showing cell-cycle inde-
pendent end resection of the rDNA breaks. However, the dis-
crepancy in the results between the two studies could be
attributed to the different timing of the resection assay. We
observed resection activity at early time points, and in particular
within the first 2 h after transfection of the I-Ppo1 mRNA. At
later time points (4 h), we also started to detect resection activity
in G1-phase cells, especially in untransformed RPE-1 cells
(Supplementary Fig. 7a, b), consistent with the data published by
van Sluis and McStay, who assessed resection exclusively at late
time points (6 h) after I-Ppo1 mRNA transfection16. We therefore
propose that prolonged exposure of cells to I-Ppo1 generates
persistent DSBs, which may be resected also in G1-phase cells.
Using live-cell imaging, we observed rapid fusion of FC and
DFC in the nucleoli upon I-Ppo1 expression throughout the cell
cycle, followed by “floating” of the fused FC and DFC to the
nucleolar surface where they remain anchored in the nucleolar
periphery. Moreover, we found that fusion of FC/DFC and
nucleolar segregation occurs downstream of ATR activation, but
independently of resection. This is remarkably different from
what was observed for DSBs induced outside of the nucleoli,
which are resected in an ATM-dependent, but ATR-independent
manner4,5.
Nucleolar material exhibits liquid-demixing behavior47. Thereby,
FC, DFC and GC within the nucleoli may represent coexisting
immiscible liquid phases determined by differences in the biophy-
sical properties of their constituents48. Ongoing transcription is an
essential element of the maintenance of nucleolar structure because
it may prevent coalescence of DFC-surrounded GCs to form larger
centers20. Thus, when transcription is inhibited, GC and DFC start
to fuse, which may induce a liquid-phase de-mixing process that
results in the “floating” of the exposed GC to the nucleolar per-
iphery. Our live-cell imaging data clearly support such a liquid-like
behavior of the nucleoli and suggests liquid de-mixing processes as
the driving force behind nucleolar segregation. In summary, we
propose that nucleolar reorganization induced by rDNA breaks
may be a consequence of inhibition of transcription resulting in
enhanced ability of FC and DFC to coalesce.
The mechanism of Pol I inhibition in response to rDNA breaks
is not yet clear. ATM-dependent inhibition of RNA polymerase II
transcription in response to DSBs has been shown to involve local
histone H2A ubiquitylation and the recruitment of a specific
chromatin remodeler as well as the cohesion complex10,11,14.
Posttranslational histone modifications also seem to be key events
in Pol I inhibition because ATM-dependent H2B S14 phos-
phorylation by MST2 kinase is required for transcriptional
repression in the nucleoli19. Direct modification of the Pol I
transcription machinery by ATM and ATR may also be involved
as several key Pol I transcription factors appear to be targeted by
PIKKs49. However, the fact that transcriptional inhibition is
dependent on both PIKK activity as well as downstream signaling
events involving CHK1 and CHK2 kinases, it is likely that more
than one effector molecule mediates DSB-induced transcriptional
inhibition in the nucleoli.
Methods
Cell culture and drug treatments. All cell lines were grown in a sterile cell culture
environment and routinely tested for mycoplasma contamination. 293FT (trans-
formed human embryonal kidney cell line), U2OS (human osteosarcoma cell line),
HeLa (cervical carcinoma cell line) and RPE-1 (immortalized human retinal pig-
mented cell line) cells were cultured in Dulbecco’s modified Eagle medium
(DMEM), supplemented with 10% fetal calf serum (FCS), 2 mM L-glutamine and
penicillin–streptomycin antibiotics under standard cell culture conditions in a CO2
incubator (37 °C; 5% CO2). U2OS cell lines stably transfected with GFP-Treacle
and tetracyclin repressor expression constructs were cultured in the presence of
200 μg/ml Zeocin and 10 μg/ml Blasticidin S (Invitrogen). U2OS cell lines stably
transfected with NBS1-mNG expression constructs and with GFP-ATR expression
constructs (gift from J. Lukas) were cultured in the presence of 1 μg/ml Puromycin.
For pulsed EU incorporation, cells were incubated for 30 min in medium con-
taining 1 mM EU. The Click-iT EU Alexa Fluor 594 Imaging Kit (Thermo Fisher
Scientific) was used for EU detection. Unless stated otherwise, the following
compounds were used at the indicated final concentrations: ATM inhibitor KU-
55933 (5 μM; Selleckchem), ATR inhibitor VE-821 (5 μM; Selleckchem), ATR
inhibitor HY-19323 (5 μM; MedChemExpress), CHK1/CHK2 inhibitor AZD7762
(300 nM; TargetMol), CHK1 inhibitor GDC-0575 (300 nM; MedChemExpress). X-
ray irradiation of cells was performed with a YXLON.SMART 160E-1.5 device
(150 kV, 6 mA; YXLON International SA) delivering 11.8 mGy per second. Soft X-
rays were largely filtered out with a 3-mm aluminum filter.
Cloning and mutagenesis. The pcDNA4-TO-strep-HA-GFP-Treacle construct for
GFP-Treacle expression, the deletion mutants F1-F5 and the point mutant S171A/
T173A/T203A/T210A (STTT) has been described21. Mutant derivatives S1236A,
S1227A/S1228A and S1227A/S1228A/S1236A of this construct were generated by
site-directed mutagenensis using the QuikChange II Site-Directed Mutagenesis kit







pcDNA5/FRT/TO-NBS1-mNG were generated by PCR amplification of mNG
from pmNeonGreen-C1 (Allele Biotechnology) and ligation into pcDNA5/FRT/
TO-NBS1-WT, -R28A, -K160M and R28A/K160M, respectively50. Plasmids pIRES
V5 I-Ppo1 and pIRES I V5 -Ppo1(H98A) for I-Ppo1 mRNA purification (gift from
Brian McStay) were described16. pIRESneo2-TOPBP1-WT, -K154A/K155A
(BRCT1), -K704A (BRCT5), -K1317A (BRCT7) were described37,51,52. The mutant
derivative W1145R of this construct was generated by site-directed mutagenensis
using the QuikChange II Site-Directed Mutagenesis kit (Agilent Technologies).
Sequences of the mutagenesis primers were:
Fig. 6 A conserved TOPBP1 phospho-interaction motif in Treacle. a HA-immunoprecipitations from 293FT cells transfected with the indicated HA-tagged
Treacle variants. b TOPBP1 localization 2 h after I-Ppo1 transfection in GFP-Treacle-expressing cell lines after treatment with control siRNA (left panel) and
Treacle siRNA (right panel). c Quantification of the experiment in b, mock: siCtrl (n= 301) versus siTreacle (n= 290), WT: siCtrl (n= 226) versus
siTreacle (n= 242), S1236A: siCtrl (n= 75) versus siTreacle (n= 79), S1227A/S1228A: siCtrl (n= 169) versus siTreacle (n= 177) and S1227A/S1228A/
S1236A: siCtrl (n= 77) versus siTreacle (n= 69) cells. d Quantification of nucleolar EU incorporation after I-Ppo1 transfection in GFP-Treacle-expressing
cell lines after treatment with control siRNA and Treacle siRNA. WT: siCtrl (n= 216) versus siTreacle (n= 200), S1236A: siCtrl (n= 224) versus siTreacle
(n= 224), S1227A/S1228A: siCtrl (n= 222) versus siTreacle (n= 227) and S1227A/S1228A/S1236A: siCtrl (n= 229) versus siTreacle (n= 232) cells.
c, d Statistical significance was calculated using a one-way analysis of variance and Sidak’s multiple comparison test. Bars represent mean ± S.D. All scale
bars= 10 µm. Source data are provided as a Source Data file.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13981-x ARTICLE
NATURE COMMUNICATIONS |          (2020) 11:123 | https://doi.org/10.1038/s41467-019-13981-x | www.nature.com/naturecommunications 11






















































































GFP-TOPBP1DAPI ATR Merge D/G/A




Fig. 7 Treacle- and TOPBP1-mediated nucleolar recruitment of ATR. a ATR localization in Treacle- and TOPBP1-depleted U2OS cells and control cells 2 h
after I-Ppo1 transfection. b Quantification of the experiment in a, siCtrl (n= 364), siTreacle (n= 214) and siTOPBP1 (n= 245) treated cells. Statistical
significance was calculated using a one-way analysis of variance and Sidak’s multiple comparison test. Bars represent mean ± S.D. c ATR localization in
293-T cells overexpressing GFP-TOPBP1 wild type and W1145R AAD point mutant. d UBF localization in Hela cells overexpressing GFP-TOPBP1 and
transfected with control siRNA and Treacle siRNA, respectively. All scale bars= 10 µm. Source data are provided as a Source Data file.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13981-x



















































































































































Fig. 8 Loss of Treacle and TOPBP1 impairs rDNA repair. a γH2AX, 53BP1, RPA2, RAD51 and BRCA1 localization in control depleted (siCtrl) and Treacle-
depleted (siTreacle) U2OS cells 2 h after I-Ppo1 transfection. b Quantification of the experiment in a, γH2AX: siCtrl (n= 177) versus siTreacle (n= 200),
53BP1: siCtrl (n= 261) versus siTreacle (n= 239), RPA2: siCtrl (n= 152) versus siTreacle (n= 168) BRCA1: siCtrl (n= 525) versus siTreacle (n= 246)
and RAD51: siCtrl (n= 525) versus siTreacle (n= 246) cells (all datapoints are shown, bar represents mean, error bars represent S.D.) c γH2AX, 53BP1,
RPA2, RAD51 and BRCA1 localization in control depleted (siCtrl) and TOPBP1-depleted (siTOPBP1) U2OS cells 2 h after I-Ppo1 transfection.
d Quantification of the experiment in c, γH2AX: siCtrl (n= 403) versus siTOPBP1 (n= 205), 53BP1: siCtrl (n= 239) versus siTOPBP1 (n= 256), RPA2:
siCtrl (n= 649) versus siTOPBP1 (n= 359) BRCA1: siCtrl (n= 228) versus siTOPBP1 (n= 348) and RAD51: siCtrl (n= 228) versus siTOPBP1 (n= 348)
cells (all datapoints are shown, bar represents mean, error bars represent S.D.). e Clonogenic surivival analysis of I-Ppo1-transfected control (siCtrl),
Treacle-depleted (siTreacle) and TOPBP1-depleted (siTOPBP) U2OS cells (red bars represent the mean). f Clonogenic surivival analysis of I-Ppo1-
transfected WT and NBS1DN U2OS cells (red bars represent the mean). g Model (see text for details). Source data are provided as a Source Data file.
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Generation of stable cell lines. To isolate cell lines with low GFP-Treacle
expression, U2OS cells were co-transfected with pcDNA6/TR (Invitrogen) and
pcDNA4-TO-strep-HA-GFP-Treacle21 constructs and stably transfected cells were
selected in the presence of 400 μg/ml Zeocin and 5 μg/ml Blasticidin S (Invitrogen).
Subsequently, clones with low levels of Doxycycline-independent “leaky” expres-
sion of GFP-Treacle were isolated. NBS1ΔN cells stably expressing NBS1-mNG
were generated by co-transfection of pcDNA5/FRT/TO-NBS1-mNG with pBabe-
Puro, followed by selection with 1 μg/ml Puromycin. To isolate cell lines with
homogenous NBS1-mNG expressing, pooled colonies were sorted using a BD
FACSAria II 4L cell sorter.
Generation and characterization of the NBS1ΔN cell line. For the generation of
NBS1 knock-out cells, the sgRNA target sequence (50-GCGTTGAGTACGTTGT
TGGA-30) was cloned into the PX330-U6-hSpCas9 vector and verified by sequen-
cing. The targeting vector was then transfected into U2OS cells, and clonal cell lines
were isolated by dilution in 96-well plates. Single clones were analyzed for NBS1
expression by immunofluorescence50. Several clones without detectable NBS1
expression were isolated and one of them was further characterized. Frame-shift-
inducing insertion/deletion (indel) mutations in all of the three NBS1 alleles present
in U2OS cells were verified by Sanger sequencing of a PCR-amplified genomic
fragment that was cloned in the pCR II Blunt TOPO plasmid.
RNA transfection. The control siRNA (siCtrl) and siRNA against Treacle
(siTreacle), TOPBP1 (siTOPBP1), ATR (siATR) and CtIP (siCtIP) were obtained
from Microsynth AG. The sequences of the siRNAs were: siCtrl: UGGUUUACA
UGUCGACUAA-dTdT, siTreacle: CCACCAUGGGUUGGAACUAAAUU-dTdT,
siTOPBP1: ACAAAUACAUGGCUGGUUA-dTdT, siATR: CCUCCGUGAUGUU
GCUUA-dTdT and siCtIP: GCTAAAACAGGAACGAATC-dTdT. Cells were
grown in six-well plate 24 h prior the transfection. The siRNA transfection was done
with 10 pM siRNA using Lipofectamine RNAiMAX (Invitrogen). Cells were split on
coverslips 24 h after the transfection and harvested 72 h after the transfection.
For the generation of the in vitro transcribed I-Ppo1, we used the vectors pIRES
I-Ppo1 wild type and H98A (a gift from Brian McStay16). Plasmids were linearized
with NotI and transcribed in vitro using the MEGAscript T7 kit (Ambion)
according to the manufacturer’s instructions. The I-Ppo1 mRNA was then
polyadenylated using the Poly(A) tailing kit (Ambin) according to the
manufacturer’s instructions. For I-Ppo1, mRNA transfection cells were grown on
glass coverslips in six- or 24-well plate 24 h prior the I-Ppo1 transfection. The
mRNA transfection was done using the Lipofectamine MessengerMax Reagent
(Invitrogen) according to the manufacturer’s instruction.
SDS-PAGE and western blotting. SDS-PAGE and western blotting were per-
formed using BioRad 4–15% Mini-PROTEAN TGXTM Precast Gels. Additional
SDS-PAGE and western blotting was done using Bolt 4–12% Bis-Tris Plus gels
from Thermo Fisher Scientific. The following antibodies were used at the indicated
dilutions: BLM (goat, Abcam, ab5446, 1/500), GFP (mouse, Roche, 11814460001,
1/5000), HA (mouse, Santa Cruz Biotechnology, sc-57592, 1/1000), NBS1 (rabbit,
Abcam, ab32074, 1/2000), NBS1 (mouse, GeneTex, GTX70224, 1/1000), TOPBP1
(A300-111A, Bethyl Laboratories, 1/5000), TOPBP1 (rabbit, Abcam, Ab2402, 1/
1500), ATM pS1981 (rabbit, Epitomics, 2152-1, 1/5000), ATM (rabbit, Calbio-
chem, PC-116, 2/250), Treacle (rabbit, Sigma, HPA038237, 1/500), RAD9 (rabbit,
Abcam, ab70810, 1/3000), RAD50 (mouse, GeneTex, 13B3, GTX70288, 1/1000),
MRE11 (mouse, Abcam, 12D7, ab214, 1/500), Tubulin (mouse, Sigma, DM1A;
T6199, 1/2000), RPA-pS4/S8 (rabbit, Bethyl laboratories, A700-009, 1/1000), RPA2
(mouse, Abcam, ab2175, 1/10000), CHK1 pS317 (rabbit, Cell Signaling, 2344, 1/
500), CHK1 pS345 (rabbit, Cell Signaling, 2348, 1/500) CHK1 (mouse, Santa Cruz
Biotechnology, sc-8408, 1/1000), CHK2 pT68 (rabbit, Cell Signaling, 2661, 1/1000),
CHK2 (rabbit, Cell Signaling, 2662, 1/1000).
Immunoprecipitations. For GFP-Trap immunoprecipitations, cells were washed
twice in phosphate-buffered saline (PBS), and lysed in IP buffer (100 mM NaCl,
0.2% Igepal CA-630, 1 mM MgCl2, 10% glycerol, 5 mM NaF, 50 mM Tris-HCl, pH
7.5), supplemented with cOmplete EDTA-free protease inhibitor cocktail and 25 U/
ml Benzonase (Novagen). After nuclease digestion, NaCl and EDTA concentra-
tions were adjusted to 200 mM and 2mM, respectively, and lysates were cleared by
centrifugation. Lysates were then incubated with 15 μl of GFP-Trap magnetic
agarose beads (ChromoTek) with end-to-end mixing at 4 °C.
Immunoglobulin–antigen complexes were washed five times with IP buffer before
elution in 2× SDS sample buffer. For HA immunoprecipitations, cells were washed
twice in PBS, and lysed in IP buffer (100 mM NaCl, 1 mM MgCl2, 2 mM EDTA,
10% glycerol, 5 mM NaF, 0.2% Nonidet 40 (IP40), 50 mM Tris-HCl, pH 7.6),
supplemented with cOmplete EDTA-free protease inhibitor cocktail and 25 U/ml
Benzonase (Novagen). After nuclease digestion, lysates were cleared by cen-
trifugation. Lysates were then incubated with 40 μl of anti HA-Agarose beads
(Sigma) with end-to-end mixing at 4 °C. Immunoglobulin–antigen complexes were
washed three times with IP buffer before elution in 2× SDS sample buffer.
GST pulldowns. GST fusion proteins were expressed in the competent Escherichia
coli expression strain BL21(DE3)pLysS (Promega) followed by protein purification
with glutathione–Sepharose beads. A total of 5 μg of purified GST-TOPBP1 BRCT
fusion proteins were mixed with 33 μl of HeLa nuclear extract (7mg/ml; Ipracell) and
incubated for 1.5 h at 4 °C. Glutathione–Sepharose beads (GE Healthcare) were added
and the suspension was incubated at 4 °C for 1.5 h on a rotating wheel. The beads were
washed three times with wash buffer (50mM Tris, pH 7.5, 150mM NaCl, 1mM DTT,
and 0.2% NP-40) and bound proteins were eluted by addition of 2× SDS sample buffer.
Immunofluorescence. Cells were grown on glass coverslips and fixed with either
ice-cold methanol for 10 min or with 4% buffered formaldehyde for 15 min at
room temperature, and subsequently permeabilized for 5 min in PBS containing
0.3% Triton X-100. Following 1 h of blocking in blocking buffer (10% FBS, 3% BSA
in PBS), primary antibody incubations were performed at 4 °C overnight. Cover-
slips were washed three times with PBS and secondary antibody incubations were
performed for 1 h at room temperature in the dark. After washing with PBS for
three times, coverslips were mounted on glass microscopy slides with Vectrashield
mounting medium containing 0.5 μg/ml 4′,6-diamidino-2-phenylindole dihy-
drochloride (DAPI). The following antibodies were used at the indicated dilutions:
Treacle (rabbit, Sigma Life Science, HPA038237, 1/100), TOPBP1 (rabbit, Bethyl,
A300-111A, 1/500), Nucleophosmin (mouse, Thermofisher, MA5-17141, 1/300),
BRCA1 (mouse, sc-6454, Santa Cruz, 1/100), RAD51 (rabbit, Santa Cruz, sc-8349,
1/100), γH2AX (mouse, Millpore, 05-636, 1/500), MDC1 (mouse, Abcam,
Ab50003, 1/300), Cyclin A (mouse, BD biosciences, 611269, 1/100), RPA2 (mouse,
Abcam, Ab2175, 1/250), RPA2 pS4/S8 (rabbit, Bethyl A300-245, 1/400), 53BP1
(mouse, gift from T. Halazonetis, 1/20) NBS1 (rabbit, Novus, NB100-143, 1/200),
MRE11 (mouse, GeneTex, GTX70212, 1/1000), UBF (mouse, Santa Cruz, sc-13121,
1/100), ATM (rabbit, Abcam, ab32420, 1/250), ATR (rabbit, Cell Signaling E1S3S,
1/100), V5 (mouse, Abcam, ab27671, 1/500).
Widefield and confocal microscopy. Widefieled image acquisition was done on a
Zeiss AxioObserver Z1 widefield microscope, equipped with a Lumencor SpectraX
illumination system and a Hamamatsu Orca Flash 4.0 V2, sCMOS, cooled fluores-
cence camera (16 bit, 2048 × 2048 pixel (4MP), pixel size 6.5 μm). A 63×, 1.4-NA, i-
plan apochromat oil-immersion objective was used. For optimal representation in
figures, images were adjusted for brightness and exported as RGB TIF files using Fiji53.
Confocal images were acquired with a Leica SP8 inverse confocal laser scanning
microscope with a 63×, 1.4-NA Plan-Apochromat oil-immersion objective. The
sequential scanning mode was used and the number of overexposed pixels was kept
at a minimum. Fields were recorded at a resolution of 512 × 512 pixels, 8 bit depth
or 1024 × 1024 pixels, 8 bit. For optimal representation in figures, maximum
intensity projections were calculated and images were adjusted for brightness and
exported as RGB TIF files using Fiji53.
Image quantification. The xyz confocal datasets (z-stacks) were analyzed using
IMARIS 9.2 (Bitplane). Caps/foci were segmented and counted by the integrated
intensity-based spot detection tool and nucleoli were surface rendered to calculate
nucleolar volume and sphericity.
Nucleolar caps and DNA damage foci were quantified using CellProfiler 3.051.
First, nuclei segmentation was performed by the intensity-based primary object
detection module using the DAPI signal. For nucleolar caps and foci segmentation,
the primary object detection module was used on the respective channels after
applying a feature enhancement filter. Downstream data manipulation and
graphical representation of the data were done using R 3.4.2 (R Development Core
Team). CellProfiler pipelines and R scripts are available upon request.
Quantification of nucleolar EU incorporation was done with Fiji53. Nucleoli
were segmented manually by using the DIC channel and a Wacom graphic tablet.
Nucleoli were marked as regions of interest (ROI) and added to the ROI manager.
Fluorescence intensities were then measured within the ROIs in the EU channel.
Time-lapse microscopy. GFP-Treacle- or NBS1-mNG-expressing cells were plated
24 h prior the imaging in the μ-Slide 8-well chamber coverslip (Ibidi). I-Ppo1
transfection was done using Lipofectamine MessengerMax Reagent (Invitrogen)
according to the manufacturer’s instruction. Cells were followed over time with a
Zeiss AxioObserver Z1 widefield microscope equipped with a Definite Focus hard-
ware autofocus control unit. Temperature and CO2 levels were kept at 37 °C and 5%
CO2 for the duration of the experiment. A 63×, 1.4-NA, i-plan apochromat oil-
immersion objective was used. Phase-contrast images and wavelength detection EGFP
were acquired at 3 min intervals over a period of 2–3 h. Movies of individual cells
were generated by applying the StackReg plugin in Fiji (Rigid body transformation) to
compensate for cell movement. Time-lapse recordings were then animated and
exported as GIF files or rendered to mp4 video files with Adobe Photoshop CC 2018.
Real-time PCR. Quantification of rRNA transcription by real-time PCR was
essentially done as described previously21. Unless otherwise indicated, RNA
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isolation and cDNA synthesis were carried out 6 h after I-Ppo1 transfection. Real-
time PCR was performed using 10 ng of cDNA with SYBR Green I Master (Roche,
Cat. no. 04707516001). Samples were analyzed on a LightCycler480 and quantified
with LightCycler480 quantification software.
Clonogenic survival assay after I-Ppo1 transfection. Cells were treated either
with control siRNA (siCtrl), siTreacle or siTOPBP1 and 48 h post transfection, cells
were transfected with I-Ppo1 mRNA. To ensure the same conditions, cells were
counted and plated in six-well plates 4 h after I-Ppo1 transfection. For each con-
dition, 1000 cells per well were plated, in triplicates. Colonies were grown for
10 days, with medium change every 4 days. Plates were washed twice in PBS and
incubated for 1 h in Methylene blue fixation/staining solution (80% EtOH, 1%
Methylene blue powder) at room temperature. After rigorous washing with warm
tap water, plates were left to dry overnight and colonies were counted manually
using an eCount™ colony counter pen.
Mass spectrometry. Mass spectrometric experiments were performed on a
nanoscale UHPLC system (EASY-nLC1000 from Proxeon Biosystems) connected to
an Orbitrap Q-Exactive HF equipped with a nanoelectrospray source (Thermo Fisher
Scientific). Peptides were auto-sampled and separated on a 15-cm analytical column
(75 μm ID) in-house packed with 1.9 μm C18 beads using a 77-min gradient ranging
from 5 to 40% acetonitrile in 0.1% formic acid at a flow rate of 250 nl per min. The
mass spectrometer was operated in data-dependent acquisition mode and all samples
were analyzed using a previously described “sensitive” acquisition method52. All raw
data analysis was performed with MaxQuant software suite54 version 1.5.3.30 sup-
ported by the Andromeda search engine55. For generation of the theoretical spectral
library, a HUMAN.fasta database was extracted from UniProt. Cysteine carbamido-
methylation was included as a fixed modification, whereas N-terminal acetylation,
methionine oxidation and phosphorylation (S, T and Y), were included as variable
modifications. Mass tolerance for precursors was set to 20 ppm in the first MS/MS
search and 4.5 ppm in the main MS/MS search. Data were automatically filtered by
posterior error probability to achieve a false discovery rate of < 1% (default), at the
peptide-spectrum match and the site-specific levels. For enrichment and mass spec-
trometric analysis of Treacle phosphopeptides, 293T cells were transfected with
pcDNA4-TO-strep-HA-GFP-Treacle and collected in high-salt RIPA buffer (50mM
Tris pH7.5, 400mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 0.1% Na-deoxycholate,
2 mM Na-orthovanadate, 5 mM NaF, 5mM glycero-2-phosphate, protease inhibitors
(Roche)). Proteins from cleared lysate were precipitated in acetone, dissolved in urea,
reduced with dithiothreitol, alkylated with chloroacetamide30, and digested using Lys-
C and modified sequencing-grade trypsin (Sigma). Protease digestion was terminated
by addition of trifluoroacetic acid and peptides were purified using reversed-phase
Sep-Pak C18 cartridges (Waters). Phosphopeptides were enriched on a TiO2 column
prior to mass spectrometry.
Statistical analysis. Graphs were generated with Prism 8 for macOS (GraphPad
Software Inc., Version 8.1.2). Unless otherwise indicated, horizontal bars represent
the mean values and error bars the standard deviation. In box plot graphs, boxes
represent the 25–75 percentile range with median, and whiskers represent the 9–95
percentile range. Data points outside this range are shown individually. Statistical
tests were applied as described in the Figure legends and were calculated with
Prism 8. In all quantitative immunofluorescence studies, at least 100 random cells
per group were scored.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The mass spectrometry proteomics data have been deposited to the ProteomeXchange
Consortium via the PRIDE56 partner repository with the dataset identifier PXD015138.
The source data underlying Figs. 1d, f–h, 2b, 3c, e, g, 4d, e, h, 5b, d, 6a, c, d, 7b and 8b–d
and Supplementary Figs. 1c–e, 3b–d, 7c and 8a are provided as a Source Data file. All
other relevant data, CellProfiler pipelines and R scripts are available from the authors
upon request.
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